Ruolo del G-CSF e GM-CSF nel trattamento dell'infarto miocardico acuto e dell'ischemia critica degli arti inferiori

Translated title of the contribution: Role of G-CSF and GM-CSF in the treatment of acute myocardial infarction and critical limb ischemia

Marco Centola, Maurizio C. Capogrossi

Research output: Contribution to journalArticle

Abstract

In spite of novel pharmacological and reperfusion strategies, many patients with acute myocardial infarction (AMI) and critical limb ischemia (CLI) due to peripheral arterial disease (PAD) have an unfavorable prognosis. Recent studies suggest that bone marrow cell mobilization with granulocyte colony-stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) may have a beneficial effect in AMI and CLI, likely due to endothelial progenitor cell-mediated angiogenesis and enhanced blood flow to the ischemic tissues. However, controversy still exists because published studies evaluated the effect of bone marrow cell mobilization in different patient populations, timing for drug administration in relationship to the acute event and to the reperfusion procedure differed, clinical endpoints and the techniques used for assessing cardiac function and volumes were not the same. Nevertheless, these small clinical studies provided useful information that helped design large phase III clinical trials and, ultimately, will establish whether bone marrow cell mobilization can have a role in AMI and CLI treatment.

Original languageItalian
Pages (from-to)1096-1108
Number of pages13
JournalGiornale Italiano di Cardiologia
Volume15
Issue number9
Publication statusPublished - Sep 1 2014

Fingerprint

Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Bone Marrow Cells
Ischemia
Extremities
Myocardial Infarction
Reperfusion
Cardiac Volume
Phase III Clinical Trials
Peripheral Arterial Disease
Therapeutics
Pharmacology
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ruolo del G-CSF e GM-CSF nel trattamento dell'infarto miocardico acuto e dell'ischemia critica degli arti inferiori. / Centola, Marco; Capogrossi, Maurizio C.

In: Giornale Italiano di Cardiologia, Vol. 15, No. 9, 01.09.2014, p. 1096-1108.

Research output: Contribution to journalArticle

@article{ed10d1ded2b24e6b84271b0e51c0466e,
title = "Ruolo del G-CSF e GM-CSF nel trattamento dell'infarto miocardico acuto e dell'ischemia critica degli arti inferiori",
abstract = "In spite of novel pharmacological and reperfusion strategies, many patients with acute myocardial infarction (AMI) and critical limb ischemia (CLI) due to peripheral arterial disease (PAD) have an unfavorable prognosis. Recent studies suggest that bone marrow cell mobilization with granulocyte colony-stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) may have a beneficial effect in AMI and CLI, likely due to endothelial progenitor cell-mediated angiogenesis and enhanced blood flow to the ischemic tissues. However, controversy still exists because published studies evaluated the effect of bone marrow cell mobilization in different patient populations, timing for drug administration in relationship to the acute event and to the reperfusion procedure differed, clinical endpoints and the techniques used for assessing cardiac function and volumes were not the same. Nevertheless, these small clinical studies provided useful information that helped design large phase III clinical trials and, ultimately, will establish whether bone marrow cell mobilization can have a role in AMI and CLI treatment.",
keywords = "Critical limb ischemia, G-CSF, GM-CSF, Myocardial infarction",
author = "Marco Centola and Capogrossi, {Maurizio C.}",
year = "2014",
month = "9",
day = "1",
language = "Italian",
volume = "15",
pages = "1096--1108",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "9",

}

TY - JOUR

T1 - Ruolo del G-CSF e GM-CSF nel trattamento dell'infarto miocardico acuto e dell'ischemia critica degli arti inferiori

AU - Centola, Marco

AU - Capogrossi, Maurizio C.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - In spite of novel pharmacological and reperfusion strategies, many patients with acute myocardial infarction (AMI) and critical limb ischemia (CLI) due to peripheral arterial disease (PAD) have an unfavorable prognosis. Recent studies suggest that bone marrow cell mobilization with granulocyte colony-stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) may have a beneficial effect in AMI and CLI, likely due to endothelial progenitor cell-mediated angiogenesis and enhanced blood flow to the ischemic tissues. However, controversy still exists because published studies evaluated the effect of bone marrow cell mobilization in different patient populations, timing for drug administration in relationship to the acute event and to the reperfusion procedure differed, clinical endpoints and the techniques used for assessing cardiac function and volumes were not the same. Nevertheless, these small clinical studies provided useful information that helped design large phase III clinical trials and, ultimately, will establish whether bone marrow cell mobilization can have a role in AMI and CLI treatment.

AB - In spite of novel pharmacological and reperfusion strategies, many patients with acute myocardial infarction (AMI) and critical limb ischemia (CLI) due to peripheral arterial disease (PAD) have an unfavorable prognosis. Recent studies suggest that bone marrow cell mobilization with granulocyte colony-stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) may have a beneficial effect in AMI and CLI, likely due to endothelial progenitor cell-mediated angiogenesis and enhanced blood flow to the ischemic tissues. However, controversy still exists because published studies evaluated the effect of bone marrow cell mobilization in different patient populations, timing for drug administration in relationship to the acute event and to the reperfusion procedure differed, clinical endpoints and the techniques used for assessing cardiac function and volumes were not the same. Nevertheless, these small clinical studies provided useful information that helped design large phase III clinical trials and, ultimately, will establish whether bone marrow cell mobilization can have a role in AMI and CLI treatment.

KW - Critical limb ischemia

KW - G-CSF

KW - GM-CSF

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84908468737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908468737&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84908468737

VL - 15

SP - 1096

EP - 1108

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 9

ER -